Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Trial of Quantitative Detection Kit for Hsp90α in Breast Cancer

NCT02324101 is registered in ClinicalTrials.gov with Beijing Protgen Biotechnology Development Co., Ltd. as lead sponsor.

NCT NCT02324101
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02324101 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Trial of Quantitative Detection Kit for Hsp90α in Breast Cancer
Lead sponsor
Beijing Protgen Biotechnology Development Co., Ltd.
Phase
Not applicable
Overall status
Unknown status
Start date
April 30, 2013
Completion date
December 31, 2014
Enrollment
1,100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer